Matthew Gall
Director of Finance/CFO at ITEOS THERAPEUTICS, INC.
Net worth: 824 252 $ as of 31/03/2024
Profile
Matthew Gall is currently the Chief Financial Officer at iTeos Therapeutics, Inc. Prior to this, he worked as the Senior Vice President-Corporate Development at Sarepta Therapeutics, Inc. from 2014 to 2020.
He completed his undergraduate degree at Bowling Green State University and earned an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ITEOS THERAPEUTICS, INC.
0.17% | 07/03/2024 | 60,429 ( 0.17% ) | 824 252 $ | 31/03/2024 |
Matthew Gall active positions
| Companies | Position | Start |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2020 |
Former positions of Matthew Gall
| Companies | Position | End |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2020 |
Training of Matthew Gall
| Bowling Green State University | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Matthew Gall
